HDL vs. HDL Cholesterol: Understanding the Distinction
HDL (high-density lipoprotein) is the actual particle—a complex structure containing proteins, lipids, and cholesterol—while HDL-C (HDL cholesterol) is simply a measurement of the cholesterol content carried within those HDL particles.
The Key Difference
HDL is a multimolecular lipoprotein particle that serves multiple physiological functions beyond just cholesterol transport 1. Think of HDL as the vehicle itself—a dynamic ferry system that carries various cargo including:
- Proteins: Primarily apolipoprotein A-I (apo A1), which is the major protein component 2, 3
- Lipids: Phospholipids and other lipid molecules
- Cholesterol: The cargo that gets measured as HDL-C
- Enzymes: Such as paraoxonase 1 (PON1) with antioxidant properties 1
HDL-C, by contrast, is merely the amount of cholesterol being transported by these HDL particles—it's what we measure on a standard lipid panel 2.
Why This Distinction Matters Clinically
HDL-C Is an Incomplete Marker
HDL-C levels do not predict the actual functionality or composition of HDL particles 4. This is a critical clinical pitfall. You can have:
- High HDL-C levels but dysfunctional HDL particles that lack protective properties 1, 5
- Normal HDL-C but low HDL particle numbers (HDL-P), which better predict cardiovascular risk 6
Recent evidence shows that HDL particle concentration (HDL-P) consistently predicts cardiovascular events better than HDL-C 6. In a pooled analysis of 15,784 participants, HDL-P remained inversely associated with MI and stroke even after adjusting for HDL-C, whereas HDL-C associations were attenuated when adjusted for HDL-P 6.
HDL Has Multiple Functions Beyond Cholesterol Transport
HDL particles perform numerous protective functions 1, 7:
- Reverse cholesterol transport: Removing cholesterol from arterial deposits and delivering it to the liver 1
- Anti-inflammatory activity: Protecting against vascular inflammation 1, 5
- Antioxidant properties: Preventing LDL oxidation through enzymes like PON1 1
- Immune function modulation 1, 7
- Glucose metabolism regulation 1
- Platelet function effects 1
None of these functions are captured by measuring HDL-C alone 4, 7.
Clinical Implications
For Risk Assessment
While HDL-C <40 mg/dL in men and <45 mg/dL in women marks increased cardiovascular risk 2, there is no sufficient evidence for any HDL-C value to be considered a treatment goal 2. This is because:
- Raising HDL-C pharmacologically has not reduced cardiovascular events in randomized trials 7, 5
- Genetic studies question whether the HDL-C relationship with cardiovascular disease is causal 7, 5
The Quality vs. Quantity Paradigm
Focus should shift from HDL-C quantity to HDL particle quality and function 4, 5. Functional measures that better predict outcomes include:
- Cholesterol efflux capacity (how well HDL removes cholesterol from cells) 7
- HDL particle number (HDL-P) 6
- Specific HDL proteins 7
Important Caveats
Extremely high HDL-C levels (>60 mg/dL) are not necessarily protective and may associate with increased risks of age-related macular degeneration, infectious disease, and all-cause mortality 7. This paradox further illustrates why HDL-C is an inadequate marker.
Practical Takeaway
When you see "HDL" on a lipid panel, you're actually seeing HDL-C—just the cholesterol measurement. The actual HDL particle is far more complex, with protective functions that depend on its protein and lipid composition, particle size, and functional capacity rather than its cholesterol content 8, 4, 7. For clinical decision-making, HDL-C remains useful for risk stratification but should not be a therapeutic target 2, 3.